Furthermore, immunohistochemistry was performed on microarrays of RCC samples to assess the expression levels of iNOS (a marker for M1 macrophages), CD8 (a marker for CD8+ T cells), and PBRM1. This evidence concerns the gene PBRM1 and renal cell carcinoma.